The AIIB2023 Challenge organised by #ImperialCollegeLondon and supported by
#OSIC and #RoyalBromptonHospital is a part of #MICCAI2023, which will be held
from October 8th to 12th 2023 in #Vancouver Convention Centre #Canada. 🍁

Fibrotic lung disease is a progressive lung condition with no known cure,
ultimately leading to death. That's why our challenge aims to revolutionize
lung fibrosis analysis and prognosis. More importantly, we know that #imaging
#biomarkers are vital in fibrotic lung disease. They help #diagnose and
#monitor the progression of these chronic conditions by visualising and
quantifying the extent of fibrosis using advanced techniques like #CT. These
biomarkers enable accurate diagnosis, guide #treatment decisions, and predict
#prognosis, ultimately improving patient outcomes and enabling personalised
care.

As the world's first challenge focusing on fibrotic lung disease airway
segmentation and prognosis using such imaging biomarkers, we've obtained CT
data from 262 patients with fibrotic lung disease (237 with mortality labels),
collected from the largest fibrotic lung disease database, #OSIC. Each scan
comes with meticulously annotated airway structures, providing a valuable
resource for participants.

🏆 The top winners will receive prizes worth over $4000 USD and gain
recognition from the scientific community. Additionally, we'll invite the top
3 winners to Vancouver for oral presentations, giving them the opportunity to
showcase their exceptional work.

👉 To participate, please visit our #website:
https://www.yanglab.fyi/challenges.html

This year, we are tackling two exciting #tasks of #airway #segmentation and
#mortality #prediction in #lungfibrosis #patients. Choose your task, dive into
the data, and show us your skills! We look forward to seeing your submissions!
🖥 Let's revolutionize #lung #fibrosis #analysis together. ✊